ComplianceOnline
Toll Free:
+1-888-717-2436
ComplianceOnline Home

IDE Reports: Suggested Format for IDE Progress Report

  1. Basic Elements
    • IDE Number
    • Device name and indication(s) for use
    • Sponsor's name, address, phone number, and fax
    • Contact person

  2. Study Progress (Data from beginning of the study should be reported, unless otherwise indicated)
    • Brief summary of the study progress in relation to the investigational plan
    • Number of investigators/investigational sites (attach list of investigators)
    • Number of subjects enrolled (by indication or model)
    • Number of devices shipped
    • Brief summary of results
    • Summary of anticipated and unanticipated adverse effects
    • Description of any deviations from the investigational plan by investigators (since last progress report)

  3. Risk Analysis
    • Summary of any new adverse information (since the last progress report) that may affect the risk analysis; this includes preclinical data, animal studies, foreign data, clinical studies, etc.
    • Reprints of any articles published from data collected from this study
    • New risk analysis, if necessary, based on new information and on study progress

  4. Other Changes
    • Summary of any changes in manufacturing practices and quality control (including changes not reported in a supplemental application)
    • Summary of all changes in the investigational plan not required to be submitted in a supplemental application

  5. Future Plans
    • Progress toward product approval, with projected date of PMA or 510(k) submission
    • Any plans to change the investigation, e.g., to expand the study size or indications, to discontinue portions of the investigation or to change manufacturing practices (NOTE: Actual proposals for these changes should be made in a separate supplemental application).


Copyright © 2021 ComplianceOnline.com
MetricStream
Our Policies: Terms of use | Privacy